UNSPSC 51201616: Poliovirus vaccine

This classification denotes a vaccine for a species of enterovirus which is the causal agent of poliomyelitis in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection.

UNSPSC 51201616 Poliovirus vaccine is a Commodity code that covers immunization biologics procured by state health departments and other public health agencies. State and local governments use this code to acquire vaccines for routine immunization programs, disease outbreak response, and population health initiatives. The Mississippi State Department of Health represents the primary recent issuing body under this code, though the scope of work includes procurement of specified viral vaccines by state and county health authorities and related public agencies responsible for disease prevention and immunization delivery.

Recent activity shows limited transparent competitive procurement under this code. The Mississippi State Department of Health posted a sole source notice on July 13, 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026, though that notice addresses yellow fever vaccine rather than poliovirus vaccine and follows a sole source procurement path rather than open competitive bidding. The source does not identify additional representative opportunities, suggest geographic concentration, or provide pricing, quantity, or contract-term data for poliovirus vaccine specifically. Firms pursuing this code should monitor state health department procurement channels in Mississippi and other states for routine vaccine-supply RFPs, sole source notices, and framework agreements, which typically emerge on irregular schedules tied to inventory cycles and epidemiological need rather than predictable procurement calendars.